ACE inhibitors and hypoglycaemia [13]

T.W. Van Haeften; N. Kong; A. Bates; R.E.J. Ryder; M.D. Feher; S. Amiel; A.P. Davie; I.H.M. Wildenborg; J. Veenstra; P.H.J. Van der Voort; W.P. Verdegaal; J. Silberbusch; R.M.C. Herings; A. De Boer; B.H.C. Stricker; H.G.M. Leufkens; A.J. Porsius

doi:10.1016/S0140-6736(95)92148-6

ACE inhibitors and hypoglycaemia [13]

T.W. Van Haeften, N. Kong, A. Bates, R.E.J. Ryder, M.D. Feher, S. Amiel, A.P. Davie, I.H.M. Wildenborg, J. Veenstra, P.H.J. Van der Voort, W.P. Verdegaal, J. Silberbusch, R.M.C. Herings, A. De Boer, B.H.C. Stricker, H.G.M. Leufkens, A.J. Porsius

External unknown

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	125-127
Number of pages	3
Journal	The Lancet
Volume	346
Issue number	8967
DOIs	https://doi.org/10.1016/S0140-6736(95)92148-6
Publication status	Published - 3 May 1995

Keywords

antidiabetic agent
captopril
dipeptidyl carboxypeptidase inhibitor
insulin
sulfonylurea
clinical trial
controlled clinical trial
controlled study
diabetes mellitus
diabetic nephropathy
glucose metabolism
heart failure
human
hypertension
hypoglycemia
insulin metabolism
kidney function
letter
microalbuminuria
oral drug administration
priority journal

Access to Document

10.1016/S0140-6736(95)92148-6

Cite this

Van Haeften, T. W., Kong, N., Bates, A., Ryder, R. E. J., Feher, M. D., Amiel, S., Davie, A. P., Wildenborg, I. H. M., Veenstra, J., Van der Voort, P. H. J., Verdegaal, W. P., Silberbusch, J., Herings, R. M. C., De Boer, A., Stricker, B. H. C., Leufkens, H. G. M., & Porsius, A. J. (1995). ACE inhibitors and hypoglycaemia [13]. The Lancet, 346(8967), 125-127. https://doi.org/10.1016/S0140-6736(95)92148-6

@article{4c3c326884eb4179b292731f58278a6f,

title = "ACE inhibitors and hypoglycaemia [13]",

keywords = "antidiabetic agent, captopril, dipeptidyl carboxypeptidase inhibitor, insulin, sulfonylurea, clinical trial, controlled clinical trial, controlled study, diabetes mellitus, diabetic nephropathy, glucose metabolism, heart failure, human, hypertension, hypoglycemia, insulin metabolism, kidney function, letter, microalbuminuria, oral drug administration, priority journal",

author = "{Van Haeften}, T.W. and N. Kong and A. Bates and R.E.J. Ryder and M.D. Feher and S. Amiel and A.P. Davie and I.H.M. Wildenborg and J. Veenstra and {Van der Voort}, P.H.J. and W.P. Verdegaal and J. Silberbusch and R.M.C. Herings and {De Boer}, A. and B.H.C. Stricker and H.G.M. Leufkens and A.J. Porsius",

year = "1995",

month = may,

day = "3",

doi = "10.1016/S0140-6736(95)92148-6",

language = "English",

volume = "346",

pages = "125--127",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Lancet Publishing Group",

number = "8967",

}

TY - JOUR

T1 - ACE inhibitors and hypoglycaemia [13]

AU - Van Haeften, T.W.

AU - Kong, N.

AU - Bates, A.

AU - Ryder, R.E.J.

AU - Feher, M.D.

AU - Amiel, S.

AU - Davie, A.P.

AU - Wildenborg, I.H.M.

AU - Veenstra, J.

AU - Van der Voort, P.H.J.

AU - Verdegaal, W.P.

AU - Silberbusch, J.

AU - Herings, R.M.C.

AU - De Boer, A.

AU - Stricker, B.H.C.

AU - Leufkens, H.G.M.

AU - Porsius, A.J.

PY - 1995/5/3

Y1 - 1995/5/3

KW - antidiabetic agent

KW - captopril

KW - dipeptidyl carboxypeptidase inhibitor

KW - insulin

KW - sulfonylurea

KW - clinical trial

KW - controlled clinical trial

KW - controlled study

KW - diabetes mellitus

KW - diabetic nephropathy

KW - glucose metabolism

KW - heart failure

KW - human

KW - hypertension

KW - hypoglycemia

KW - insulin metabolism

KW - kidney function

KW - letter

KW - microalbuminuria

KW - oral drug administration

KW - priority journal

U2 - 10.1016/S0140-6736(95)92148-6

DO - 10.1016/S0140-6736(95)92148-6

M3 - Letter

SN - 0140-6736

VL - 346

SP - 125

EP - 127

JO - The Lancet

JF - The Lancet

IS - 8967

ER -